medigraphic.com

2015, Number S3

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2015; 53 (S3)

Glycosylated hemoglobin A1c as a diagnostic test for diabetes mellitus in adolescents with overweight and obesity

Rivera-Hernández A, Zurita-CruzJN, Garrido-Magaña E, Fiorentini-Fayad GM, Nishimura-Meguro E

Language: Spanish
References: 16
Page: 294-299
PDF size: 266.91 Kb.


ABSTRACT

Background: In 2009 it was introduced a new diagnostic criteria based on hemoglobin A1c (HbA1c) ≥ 6.5 % in the adult population; some studies suggest that the cutoff may be smaller in pediatric population. The objective was to determine the utility of HbA1c ≥ 6.5 % as a diagnostic test for DM in Mexican adolescents with overweight or obesity.
Methods: Full somatometry was performed. Also, Tanner stage, blood pressure, blood glucose, glucose tolerance curve (GTC) and HbA1c were analyzed. Specificity, sensitivity, positive and negative predictive values and ROC curve were calculated for the diagnosis of DM with HbA1c.
Results: 109 adolescents between 10 and 16 years referred for obesity or overweight plus comorbidities were studied; 58 % were females, the age was of 13 ± 1.74 years, the BMI percentile 95.3, and the HbA1c 5.73 ± 0.9 %. It was made a diagnosis of DM in 9 cases (8.3 %), prediabetes in 8 (7.3 %) and normal glucose tolerance in 92 (84.4 %). The HbA1c mean was 5.6 ± 0.04, 5.7 ± 0.4, and 5.6 ± 0.73 %, respectively. HbA1c ≥ 6.5 % had a sensitivity of 12.5 %, a specificity of 89.8 %, a PPV of 10.65 and a NPV of 14.28. The best cutoff point for diagnosing DM through ROC curve was 5.45 %, with a sensitivity of 62.5 %, a specificity of 57.1 %, PPV 2.53 and NPV 33.3.
Conclusions: The level of HbA1c ≥ 6.5 % had low sensitivity and specificity for the diagnosis of DM. A lower cutoff point is insufficient to use HbA1c as a diagnostic criterion. These results are consistent with the ones of other journals.


REFERENCES

  1. American Diabetes Assciation. Diagnosis and classification of diabetes mellitus. Diabetes Care 2012;35(Suppl 1):S64-71.

  2. Ávila-Burgos L, Cahuana-Hurtado L, González- Domínguez D, Aracena-Genao B, Montañez-Hernández JC, Serván-Mori EE, Rivera Peña. Cuentas en diabetes mellitus, enfermedades cardiovasculares y obesidad [Internet]. México; 2006. Disponible en http://www.insp.mx/images/stories/Produccion/ pdf/101203_cdiabetes.pdf

  3. Libman IM, Barinas-Mitchell E, Bartucci A, Robertson R, Arslanian S. Reproducibility of the oral glucose tolerance test in overweight children. J Clin Endocrinol Metab. 2008;93(11):4231–7. Texto libre http://www. ncbi.nlm.nih.gov/pmc/articles/PMC2582565/

  4. Olaiz G, Rivera J, Shamara T, Rojas R, Villalpando S, Hernandez-Avila M, et al. Encuesta Nacional de Salud y Nutrición 2006. México: Instituto Nacional de Salud Pública; 2006. Texto libre http://ensanut.insp. mx/informes/ensanut2006.pdf

  5. Hannon TS, Rao G, Arslanian SA. Childhood obesity and type 2 diabetes mellitus. Pediatrics 2005;116(2):473-80.

  6. Violante-Ortiz R. Obesidad y diabetes tipo 2 en el niño. Una nueva epidemia. Rev Endocrinol Nutr. 2001;9(2):103-6. Texto libre http://www.medigraphic. com/pdfs/endoc/er-2001/er012k.pdf

  7. Soulimane S, Simon D, Shaw J, Witte D, Zimmet P, Vol S, et al. HbA1c, fasting plasma glucose and the prediction of diabetes: Inter99, AusDiaband D.E.S.I.R. Diabetes Res Clin Pract. 2012 Jun;96(3):392-9.

  8. American Diabetes Association. Standards of medical care in diabetes--2011. Diabetes Care 2011;34 (Suppl 1):S11-61. Texto libre http://www.ncbi.nlm.nih. gov/pmc/articles/PMC3006050/

  9. Raman PG, Maitra S. A comparative study of oral glucose tolerance test and glycated haemoglobin in high risk patients for diabetes mellitus. Int J Diab Dev Countries. 2000;20:23-37.

  10. Genuth S, Alberti KGMM, Bennett P, Buse J, Defronzo R, Kahn R, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;26(11):3160-7.

  11. Kramer CK, Araneta MRG, Barrett-Connor E. A1C and diabetes diagnosis: The Rancho Bernardo Study. Diabetes Care. 2010;33(1):101-3. Texto libre http:// www.ncbi.nlm.nih.gov/pmc/articles/PMC2797952/

  12. International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009;32(7):1327-34. Texto libre http://www.ncbi.nlm. nih.gov/pmc/articles/PMC2699715/

  13. Cowie CC, Rust KF, Byrd-Holt DD, Gregg EW, Ford ES, Geiss LS, et al. Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006. Diabetes Care. 2010;33(3):562-8. Texto libre http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC2827508/

  14. Nowicka P, Santoro N, Liu H, Lartaud D, Shaw MM, Goldberg R, et al. Utility of hemoglobin A(1c) for diagnosing prediabetes and diabetes in obese children and adolescents. Diabetes Care. 2011;34(6):1306- 11. Texto libre http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC3114343/

  15. Eldeirawi K, Lipton R. Predictors of hemoglobin A1c in a national sample of nondiabetic children: the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol. 2003;157(7):624- 32. Texto libre http://aje.oxfordjournals.org/content/ 157/7/624.

  16. Colagiuri S. Glycated hemoglobin (HbA1c) for the diagnosis of diabetes mellitus--practical implications. Diabetes Res Clin Pract. 2011;93(3):312-3.




2020     |     www.medigraphic.com